Sonora Investment Management’s Novo Nordisk NVO Stock Holding History

Sonora Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$7K	Buy	+150	New	+$7.25K	﹤0.01%	839

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sonora Investment Management's NVO Position: Q3 2021 in Review

Sonora Investment Management opened a new position in Novo Nordisk (NVO) in Q3 2021: 150 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #839 among its holdings.

804 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

Sonora Investment Management held 150 shares of Novo Nordisk worth $7K as of Q3 2021.
Novo Nordisk was a new Sonora Investment Management position in Q3 2021.
Novo Nordisk made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #839 holding.
804 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.